Nexstim Plc
Nexstim is a Finnish medical technology company focused on developing non-invasive brain stimulation technologies. The company is known for its pioneering work in transcranial magnetic stimulation (TMS) combined with 3D navigation systems. Nexstim's products are designed to provide precise and individualized stimulation of brain areas, aiding in the diagnosis and treatment of challenging brain disorders. The company's mission is to enhance patient outcomes through innovative diagnostic and therapeutic solutions.
Fiscal year 2025 · change from previous year
Development 2022–2025
Business
Share of revenueIncludes NBS 5 for brain mapping before surgery
Includes NBT® and NBS 6 for treating brain disorders
Involves sales of research devices and licenses
Customers
Nexstim's customers primarily include hospitals, clinics, and research institutions that require advanced brain mapping and stimulation technologies. These entities utilize Nexstim's systems for both diagnostic purposes, such as pre-surgical planning, and therapeutic applications, like treating severe depression and chronic pain. The company's products are particularly valued by neurosurgeons and neurologists for their precision and non-invasive nature. Nexstim also collaborates with academic institutions for research purposes, expanding its reach and application of its technologies.
Purchase diagnostic and therapeutic systems for patient care
Acquire devices for neuroscience research
Collaborate on expanding technology applications
Strategy
Nexstim's strategic priorities include expanding its market presence in Asia and enhancing its product offerings through innovation. The company focuses on developing new modules for its NBS 6 system, aiming to increase its versatility and application range. Nexstim is committed to strengthening its competitive edge by leveraging its unique navigation technology. The company also aims to grow its clinical and research partnerships to drive long-term shareholder value.
To increase global footprint and revenue
To increase product versatility and application
Geography
Nexstim operates primarily in the European Union and the United States, with a growing presence in Asia. The company is headquartered in Finland and has expanded its market reach through strategic partnerships. Nexstim's products are distributed globally, with significant installations in leading hospitals and research centers worldwide. The company continues to explore new markets, particularly in Asia, to increase its global footprint.
Risks
Nexstim faces several risks, including regulatory challenges in obtaining and maintaining approvals for its medical devices. The company is also exposed to competitive pressures from other medical technology firms. Additionally, geopolitical tensions, particularly in Asia, could impact market expansion efforts. Financial risks include fluctuations in currency exchange rates and the need for continued investment in R&D to maintain technological leadership.
Obtaining and maintaining device approvals
Presence of other medical technology firms
Accounting
Judgemental itemsAligning with delivery and acceptance criteria
Impact: Significant on reported revenue
Affecting international financial results
Impact: Moderate
Similar listed companies
Publicly listed companies with a comparable business focus.
Orion Oyj
ORNBV · Drug Manufacturers - General
Orion is a Finnish pharmaceutical company that operates globally, focusing on the development, manufacturing, and marketing of human and animal medicines, as…
Terveystalo Oyj
TTALO · Medical Care Facilities
Terveystalo is a Finnish healthcare service provider that operates through three main segments: Healthcare Services, Portfolio Businesses, and operations in Sweden.
Brainsway Ltd.
BWAY · Surgical & Medical Instruments & Apparatus
Nexalin Technology, Inc.
NXL · Electromedical & Electrotherapeutic Apparatus
Senzime
SEZI · Health Care
Senzime is a global medical technology company specializing in algorithm-based patient monitoring systems aimed at reducing anesthesia-related complications.
NeuroPace Inc
NPCE · Surgical & Medical Instruments & Apparatus
NeuroPace is a U.S.-based medical device company focused on epilepsy treatment through its implantable RNS System.
Last updated: 24/09/2026